Skip to main content
KE
NASDAQ Manufacturing

Kimball Electronics FY2026 10-K: Net Income Up 65% to $28M, Helvoet Acquisition Closed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Electrical Equipment Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$23.72
Mkt Cap
$570.441M
52W Low
$21.01
52W High
$33.19
52W Position info
13% above low
Off High info
29% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

KE is trading near its 52-week low of $21.01 (13% above the low).

Summary

Kimball Electronics' FY2026 10-K shows net income up 65% to $28M, a restated credit facility, and the completed $103M Helvoet acquisition, offset by an $8.9M withholding tax charge.


Key Events · Earnings and Guidance · KE

  • FY2026 Net Income Up 65%

    Net income rose to $28.0 million from $17.0 million, with diluted EPS of $1.13 versus $0.68, driven by gross margin improvement and a $15 million gain on the Tampa facility sale.

  • Helvoet Acquisition Closed

    Completed July 1, 2026 for approximately €90 million (~$103 million), funded with cash and existing credit lines; expands precision molded plastics and medical CDMO capabilities.

  • Dividend Withholding Tax Hit

    Recorded $8.9 million in dividend withholding tax expense in the Netherlands, including $4.4 million from Poland and $4.5 million from China, pushing the effective tax rate to 47.5%.

  • Credit Facility Extended to 2031

    Amended and restated primary credit facility on April 30, 2026, extending maturity to April 30, 2031, with $300 million revolving capacity and $92.5 million term loan outstanding.


Analysis · KE · Manufacturing

A strong fiscal 2026 saw net income climb 65% to $28.0 million and diluted EPS rise 66% to $1.13, driven by gross margin expansion and a $15 million gain on the Tampa facility sale. The balance sheet remains solid with $88.9 million in cash and a restated credit facility extending maturity to 2031. The Helvoet acquisition, closed July 1, 2026 for approximately $103 million, expands the company's medical CDMO capabilities but adds integration risk and debt. The 10-K also reveals an $8.9 million dividend withholding tax expense from unfavorable rulings in Poland and China, a one-time hit that inflated the effective tax rate to 47.5%.

At the time of this filing, KE was trading at $23.72 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $570.4M. The 52-week trading range was $21.01 to $33.19. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KE - Latest Insights

KE
Aug 12, 2026, 4:44 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.04
Real-time Price: $23.72 info
Change: -$0.320 (-1%) info
Market Cap: $570.441M info
KE
Jul 01, 2026, 7:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.49
Real-time Price: $23.72 info
Change: -$1.77 (-7%) info
Market Cap: $570.441M info
KE
Jul 01, 2026, 2:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $25.49
Real-time Price: $23.72 info
Change: -$1.77 (-7%) info
Market Cap: $570.441M info
KE
May 06, 2026, 4:49 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $25.16
Real-time Price: $23.72 info
Change: -$1.44 (-6%) info
Market Cap: $570.441M info
KE
May 06, 2026, 4:39 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $25.16
Real-time Price: $23.72 info
Change: -$1.44 (-6%) info
Market Cap: $570.441M info